Results 101 to 110 of about 73,182 (298)

Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies [PDF]

open access: bronze, 1988
John Nemunaitis   +6 more
openalex   +1 more source

Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset   +13 more
wiley   +1 more source

Clinical management of CMML—State of the art

open access: yesBritish Journal of Haematology, EarlyView.
Patients with chronic myelomonocytic leukaemia (CMML) typically present with clinical feature including splenomegaly, constitutional symptoms and autoimmune phenomena, as well as with pathological blood counts and biological features in the marrow. These characteristics may influence the assignment to prognostic categories such as the CPSSmol and also ...
K. Nachtkamp   +3 more
wiley   +1 more source

Clonal Hematopoiesis and Solid Cancers

open access: yesCancer Science, EarlyView.
This review explores the relationship between clonal hematopoiesis and solid cancers. Clonal hematopoiesis mutations influence the tumor microenvironment by altering immune regulation, inflammation, and angiogenesis. Understanding these mutations has important clinical implications, including their role in prognosis, treatment response, and potential ...
Yen T. M. Nguyen   +3 more
wiley   +1 more source

Tumor‐Associated Neutrophils Regulate Breast Cancer Progression Through the AQP9/STAT3 Signaling Pathway

open access: yesCancer Science, EarlyView.
Tumor‐associated neutrophils (TANs) enhance STAT3 phosphorylation by upregulating aquaporin 9 (AQP9) to promote breast cancer (BC) progression. AQP9 may be crucial for TAN‐mediated BC progression and is a novel target for immunotherapy in patients with BC.
Wuqin Xu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy